Daily MaverickBABOONS OP-ED: Baboon capture came with a dodgy explanation — was this ethical window dressing?The Jerusalem PostHerzog denounces 'horrific bloodshed' in Arab society, demands government action on crime3DNews«Уже знаю, во что буду играть завтра»: Devolver устроила бесплатную раздачу конкурента GTA VI для тех, кто удалит GTA VIZDF heuteAktuelle Pressemitteilungen des ZDFABC NewsTrump Asia trip live updates: Trump greets Putin, Xi as APEC summit beginsGlobal NewsRaptors forward Barnes out against WizardsPolsat NewsPo poronieniu musiała jeździć z płodem "tam i z powrotem". Koszmar w OleśnicyDeadlineSam Altman On ‘Artificial’ Movie About Him — Not Among “Ten Weirdest Things In My Life” Right Nowynet1,000 ימים בלי קצה חוט: "היימנוט חייבת לחזור"NU.nlTurks beursschandaal legt zwakke plekken in Erdogans politieke systeem blootESPNEagles' Sirianni sticking with Milton as QB1, Mannion as offensive playcallerCBS News"No indication" outages are related to cyberattacks, officials say
The Daily Newsstand · Free, Always
Wednesday, November 18, 2026

New grant program offers Israeli 'deep-tech' projects up to $1.5 million in funding

Translate

Amid a push in Israel's innovation ecosystem to develop new, commercially viable "deep-tech" products, a new Israeli grant program offering researchers up to $1.5 million over two years to help turn scientific breakthroughs into commercial technologies was announced on Monday.

The Bridge to Impact Grant, launched by Nevo Labs in partnership with Yad Hanadiv and other founding partners, will provide selected deep-tech projects with phased philanthropic funding to support research and development, along with professional mentorship and connections to industry experts.

The program targets projects based on scientifically validated discoveries or foundational technologies that have reached the applied development stage.

Funding will cover team salaries, materials, equipment, intellectual property expenses, and regulatory costs as researchers test their discoveries outside the laboratory and work to establish proof of concept, develop working prototypes, license technologies, or start companies. Similar support has helped Israeli biotech startups like X-tosis move laboratory research toward clinical application.

Grants will be disbursed in stages, contingent on meeting milestones outlined in each project's work plan. Because the funding is structured as a philanthropic grant, it will not require changes to existing intellectual property arrangements at academic institutions, according to the program.

Team of Nevo Labs, the organization in charge of the program.
Team of Nevo Labs, the organization in charge of the program. (credit: Hanna Taieb)

Dr. Asher Ragen, director of academic excellence at Yad Hanadiv, emphasized the importance of helping researchers move beyond laboratory testing.

“Israeli science holds tremendous potential to make a positive impact on the world. To realize that potential, researchers must receive comprehensive support in testing their findings under real-world field conditions and building an effective commercialization pathway,” he said.

“This new program is an innovative addition that will help scientists, academic institutions, and the State of Israel realize the potential of the exceptional science produced here,” he pointed out.

Connecting Israeli researchers with industry experts

Beyond financial support, the program will provide each participating team with three mentors selected from a pool of candidates proposed by Nevo Labs: an entrepreneur with hands-on experience, an active early-stage investor, and a senior scientist experienced in commercializing research.

A dedicated program manager will coordinate the mentors and other experts while connecting researchers with a network of scientists, entrepreneurs, investors, and industry leaders in Israel and internationally.

Sender Cohen, founding chairman of Nevo Labs and managing partner at ExB Group, highlighted the value of practical industry experience in helping researchers scale their technologies.

“When a team plans to move a process from the laboratory to a production line, someone who has already done it can help them anticipate where the process might break down as scale increases.”

“We want to connect researchers with people who hold that experience while they are still deciding what to test in their next experiment,” he added.

The program aims to "strengthen Israel's scientific and technological ecosystem by establishing new infrastructure, expanding opportunities for outstanding researchers, and increasing the number of scientific discoveries that reach their full potential."

According to the announcement, these efforts are also intended to contribute to the Israeli economy and reinforce the country's commitment to investing in science and innovation.

Alex Tsigutkin, founder of AxiomSL, president of the Dijeruma Charitable Fund, and a founding partner of the Bridge to Impact Grant, underscored the potential economic benefits of turning scientific discoveries into commercial technologies.

“True commercial success begins when a discovery evolves into a real-world solution, grows into a platform, and ultimately gives rise to an entirely new industry.”

“Israel can benefit tremendously when her entrepreneurs commit to fulfill their potential,” he pointed out.

Supporting innovation from the laboratory to the market

The program will be operated by Nevo Labs, the multidisciplinary hub of the Nevo Science Foundation, a nonprofit organization established by investors from Israel and the US.

Its founding partners include Yad Hanadiv, Alex Tsigutkin, Alan Howard, and the Nevo Labs Board of Directors. Scott Tobin, senior partner at Battery Ventures, said that the importance of demonstrating practical applications for emerging technologies.

“When I evaluate a technology coming out of a lab, I ask who will try it first and what result will convince them to keep using it.”

“Once there is an answer, the team can define what they need to prove for the technology to move from an experiment to ongoing use,” he noted.

Scott Friedman, co-founder and partner at Soroban Capital Partners, highlighted the benefits of developing technologies in Israel while preparing them for international markets.

“When researchers lead development in Israel, they accumulate local experience here that can also be applied to future projects.”

“International partners can help the team understand early on which requirements recur across different markets, enabling them to develop technology in Israel that can also serve markets abroad,” he added.

View the original on The Jerusalem Post →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.